A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 65
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AR
Long Form : area at risk
No. Year Title Co-occurring Abbreviation
2019 Safety and efficacy of global intracoronary administration of cardiosphere-derived cells or conditioned medium immediately aftercoronary reperfusion in rats. CDCs, CM, CM, GIA, MI, WKY
2018 Pharmacologic inhibition of the mitochondrial Na+/Ca2+ exchanger protects against ventricular arrhythmias in a porcine model of ischemia-reperfusion. IS
2017 Naproxen and Diclofenac Attenuate Atorvastatin-induced Preconditioning of the Myocardium. COX-2, IS, NSAIDs
2016 Absolute coronary blood flow measurement and microvascular resistance in ST-elevation myocardial infarction in the acute and subacute phase. AMI, CMR, IMR, PPCI, STEMI
2016 CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia-Reperfusion Injury. IRI, LA, MI
2015 Two-dimensional longitudinal strains and torsion analysis to assess the protective effects of ischemic postconditioning on myocardial function: a speckle tracking echocardiography study in rabbits. AN, CCs, I/R, IPostC, LV, PSI, SRivr, Ssys, STE
2014 Characteristics of cerebral ischemia in major rat stroke models of middle cerebral artery ligation through craniectomy. bCCA, CCA, IS, LMCA, MCA, sBFV
2012 Stromal cell derived factor-1 (SDF-1) targeting reperfusion reduces myocardial infarction in isolated rat hearts. AN, I/R, SDF-1
2011 Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice. AL, IS, VA
10  2010 Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size. IS, LV, PIO
11  2010 Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin. COX2, CREB, DIP, eNOS, IS, SIM
12  2009 Very mild hypothermia during ischemia and reperfusion improves postinfarction ventricular remodeling. I/AR, LV
13  2009 [Myocardial infarction remodeling in rats with dinitrosyl iron complex with glutathione]. ADCA, DNIC-GS
14  2007 Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging. AW, LV, MI, ROC, SR, TEI
15  2007 Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. ATV, COX2, IS
16  2007 Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart. IHH, IP, IS, PI3K, VT
17  2007 The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. ATV, CIL, eNOS, IS, PKA
18  2006 Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. ATV, COX-1, iNOS, IS
19  2005 Acute effect of cerivastatin on cardiac regional ischemia in a rat model mimicking off-pump coronary surgery. Cx, IF, LAD
20  2005 Grade 3 ischemia on the admission electrocardiogram predicts rapid progression of necrosis over time and less myocardial salvage by primary angioplasty. IS
21  2004 High-frequency electrical stimulation of femoral nerve reduces infarct size following myocardial ischemia-reperfusion in rats. FNES, IA, IS
22  2004 [Limb ischemic preconditioning reduces infarct size following myocardial ischemia-reperfusion in rats]. FNS, IA, IS, LIP
23  2003 Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat. LAD
24  2002 Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis. IS
25  2002 Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits. 8-PT, Ca, IS
26  2000 Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. IA
27  2000 Location as a determinant of myocardial infarction in rabbits. RMBF
28  1999 Colchicine inhibits isoflurane-induced preconditioning. IS, IS
29  1998 Hypothermia extends the cardioprotection by ischaemic preconditioning to coronary artery occlusions of longer duration. CAO, IA
30  1997 Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit. ICAM-1
31  1997 Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. AN
32  1996 Acute Ethanol Does Not Protect Against Ischemic/Reperfusion Injury in Rabbit Myocardium. TTC
33  1996 Assessment of myocardial area at risk by technetium-99m sestamibi during coronary artery occlusion: comparison between three tomographic methods of quantification. ---
34  1996 Myocardial protection by brief ischemia in noncardiac tissue. CAOs, IA
35  1996 Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists. AN, ET, mRNA
36  1996 Volume expansion increases right ventricular infarct size in dogs by reducing collateral perfusion. RV
37  1995 Does cardiopulmonary bypass alone elicit myoprotective preconditioning? IS, PC
38  1995 Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? AN, PKC
39  1995 Does protein kinase C play a role in ischemic preconditioning in rat hearts? PKC, VT
40  1995 Endocardial and epicardial infarct size after preconditioning by a partial coronary artery occlusion without intervening reperfusion. Importance of the degree and duration of flow reduction. IA, REP, TCO
41  1995 Is There a Gender Difference in Infarct Size and Arrhythmias Following Experimental Coronary Occlusion and Reperfusion? AN, VF, VT
42  1995 Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. ICAM-1, IS, MPO, RMBF
43  1994 A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. A1-R, R-PIA, SPT, VEH
44  1994 Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. AN
45  1994 Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat. IS
46  1994 Ischaemic preconditioning by partial occlusion without intermittent reperfusion. IS
47  1993 Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. ADO
48  1993 Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140. ACE, AI, i.v, IS, LVP
49  1993 Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits. i.v, IL-8
50  1992 Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids. AN
51  1992 Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. 8-PT, ADO, IS
52  1991 Hyperoxemic reperfusion does not increase myocardial infarct size. AI
53  1990 Influence of reflow ventricular fibrillation and electrical defibrillation on infarct size in a canine preparation of myocardial infarction. IS, RPP
54  1990 Myocardial protection by verapamil and reperfusion following coronary occlusion. AN, AR-AN, VP
55  1990 Myocardial protection with preconditioning. IS, LCX, LV
56  1990 The relationship between neutrophils and increased microvascular permeability in a model of myocardial ischaemia and reperfusion in the rabbit. PAF
57  1989 Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. AN
58  1989 Myocardial protection by a left ventricular assist device during reperfusion following acute coronary occlusion. AI, LVAD
59  1988 Pulmonary complications of a roller pump right ventricular assist device. AI, RCA, RV, RVAD, TLW
60  1987 A comparison of methods for limiting myocardial infarct expansion during acute reperfusion--primary role of unloading. AI, LAD
61  1986 Contrast echocardiography in acute myocardial ischemia. III. An in vivo comparison of the extent of abnormal wall motion with the area at risk for necrosis. AWM
62  1984 Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques. HR, ISA, LV
63  1982 Limitation of myocardial infarct size after surgical reperfusion for acute coronary occlusion. AN, LAD, TTC
64  1982 Transmural variation in the relationship between myocardial infarct size and risk area. IA, LV, PPM
65  1981 Demonstration of lateral and epicardial border zone salvage by flurbiprofen using an in vivo method for assessing myocardium at risk. ---